Effect of Addition of Dronedarone to Standard Rate Control Therapy on Ventricular Rate During Persistent Atrial Fibrillation (AFRODITE)

NCT01047566 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: Dronedarone
DRUG: Beta blocker or calcium antagonist or digoxin

Sponsor

Sanofi